Barclays’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.89M | Sell |
147,242
-363,998
| -71% | -$4.64M | ﹤0.01% | 2387 |
|
|
2025
Q4 | $4.6M | Buy |
511,240
+23,014
| +5% | +$317K | ﹤0.01% | 2281 |
|
|
2025
Q3 | $8.43M | Sell |
488,226
-29,921
| -6% | -$369K | ﹤0.01% | 1800 |
|
|
2025
Q2 | $4.86M | Buy |
518,147
+278,051
| +116% | +$2.28M | ﹤0.01% | 2161 |
|
|
2025
Q1 | $1.71M | Sell |
240,096
-71,536
| -23% | -$723K | ﹤0.01% | 2740 |
|
|
2024
Q4 | $3.63M | Buy |
311,632
+18,837
| +6% | +$294K | ﹤0.01% | 2434 |
|
|
2024
Q3 | $6.02M | Buy |
292,795
+89,422
| +44% | +$2.06M | ﹤0.01% | 1928 |
|
|
2024
Q2 | $4.55M | Buy |
203,373
+18,078
| +10% | +$430K | ﹤0.01% | 1605 |
|
|
2024
Q1 | $5.1M | Sell |
185,295
-166,035
| -47% | -$4.61M | ﹤0.01% | 1838 |
|
|
2023
Q4 | $10.7M | Buy |
351,330
+94,704
| +37% | +$2.72M | 0.01% | 1468 |
|
|
2023
Q3 | $8.11M | Buy |
256,626
+33,558
| +15% | +$1.3M | 0.01% | 1085 |
|
|
2023
Q2 | $9.1M | Sell |
223,068
-2,585
| -1% | -$105K | 0.01% | 1026 |
|
|
2023
Q1 | $8.41M | Sell |
225,653
-34,214
| -13% | -$1.34M | 0.01% | 1249 |
|
|
2022
Q4 | $9.07M | Buy |
259,867
+75,296
| +41% | +$3.58M | 0.01% | 1250 |
|
|
2022
Q3 | $10.3M | Buy |
184,571
+77,673
| +73% | +$4.82M | 0.01% | 847 |
|
|
2022
Q2 | $5.53M | Buy |
106,898
+6,061
| +6% | +$308K | 0.01% | 1283 |
|
|
2022
Q1 | $7.33M | Sell |
100,837
-37,922
| -27% | -$3.21M | 0.01% | 1039 |
|
|
2021
Q4 | $16.4M | Buy |
138,759
+62,574
| +82% | +$7.84M | 0.01% | 1024 |
|
|
2021
Q3 | $10.2M | Buy |
76,185
+35,823
| +89% | +$5.42M | 0.01% | 1182 |
|
|
2021
Q2 | $6.53M | Sell |
40,362
-52,505
| -57% | -$4.09M | 0.01% | 1436 |
|
|
2021
Q1 | $7.45M | Buy |
92,867
+75,801
| +444% | +$5.09M | 0.01% | 1225 |
|
|
2020
Q4 | $928K | Sell |
17,066
-12,993
| -43% | -$472K | ﹤0.01% | 2806 |
|
|
2020
Q3 | $597K | Buy |
30,059
+22
| +0.1% | +$459 | ﹤0.01% | 3101 |
|
|
2020
Q2 | $632K | Buy |
30,037
+3,874
| +15% | +$65.8K | ﹤0.01% | 3152 |
|
|
2020
Q1 | $320K | Sell |
26,163
-19,364
| -43% | -$261K | ﹤0.01% | 3942 |
|
|
2019
Q4 | $668K | Buy |
45,527
+25,989
| +133% | +$362K | ﹤0.01% | 4042 |
|
|
2019
Q3 | $260K | Sell |
19,538
-5,706
| -23% | -$91K | ﹤0.01% | 4767 |
|
|
2019
Q2 | $413K | Buy |
25,244
+15,725
| +165% | +$247K | ﹤0.01% | 4495 |
|
|
2019
Q1 | $162K | Sell |
9,519
-5,768
| -38% | -$86K | ﹤0.01% | 4978 |
|
|
2018
Q4 | $209K | Sell |
15,287
-1,018
| -6% | -$18.9K | ﹤0.01% | 4545 |
|
|
2018
Q3 | $466K | Buy |
16,305
+8,839
| +118% | +$257K | ﹤0.01% | 4334 |
|
|
2018
Q2 | $205K | Sell |
7,466
-12,312
| -62% | -$298K | ﹤0.01% | 4701 |
|
|
2018
Q1 | $416K | Buy |
19,778
+10,483
| +113% | +$258K | ﹤0.01% | 4158 |
|
|
2017
Q4 | $179K | Buy |
9,295
+2,367
| +34% | +$54.6K | ﹤0.01% | 4779 |
|
|
2017
Q3 | $172K | Buy |
6,928
+4,849
| +233% | +$91.3K | ﹤0.01% | 4552 |
|
|
2017
Q2 | $33K | Sell |
2,079
-16,793
| -89% | -$235K | ﹤0.01% | 5558 |
|
|
2017
Q1 | $267K | Buy |
18,872
+7,659
| +68% | +$103K | ﹤0.01% | 4035 |
|
|
2016
Q4 | $148K | Buy |
11,213
+11,145
| +16,390% | +$167K | ﹤0.01% | 4455 |
|
|
2016
Q3 | $1K | Sell |
68
-422
| -86% | -$8.17K | ﹤0.01% | 6410 |
|
|
2016
Q2 | $10K | Buy |
+490
| New | +$13K | ﹤0.01% | 5543 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
